RES-1149-1
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Bioactive by-products |
| Catalog number | BBF-03363 |
| CAS | |
| Molecular Weight | 386.5 |
| Molecular Formula | C23H30O5 |
Online Inquiry
Description
RES-1149-1 is an endothelin type B receptor antagonist produced by Aspergillus sp. RE-1149. It selectively inhibits the ET-1 binding to endothelin type B receptor with IC50 value of 1.5 µmol/L.
Specification
| IUPAC Name | [(1R,4S,4aS,8aS)-3,4-diformyl-4-hydroxy-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] (2E,4E,6E)-octa-2,4,6-trienoate |
| Canonical SMILES | CC=CC=CC=CC(=O)OC1C=C(C(C2(C1C(CCC2)(C)C)C)(C=O)O)C=O |
| InChI | InChI=1S/C23H30O5/c1-5-6-7-8-9-11-19(26)28-18-14-17(15-24)23(27,16-25)22(4)13-10-12-21(2,3)20(18)22/h5-9,11,14-16,18,20,27H,10,12-13H2,1-4H3/b6-5+,8-7+,11-9+/t18-,20+,22+,23-/m1/s1 |
| InChI Key | ZWNZDIPJNHSCRQ-MOHQOPMHSA-N |
Reference Reading
1. RES-1149-1 and -2, novel non-peptidic endothelin type B receptor antagonists produced by Aspergillus sp. I. Taxonomy of producing strain, fermentation, isolation, and physico-chemical and biological properties
T Ogawa, K Ando, T Tanaka, Y Uosaki, Y Matsuda J Antibiot (Tokyo). 1996 Jan;49(1):1-5. doi: 10.7164/antibiotics.49.1.
RES-1149-1 and -2, novel and non-peptidic endothelin antagonists, were isolated from the cultured broth of a fungus, Aspergillus sp. RE-1149. RES-1149-1 and -2 selectively inhibited the ET-1 binding to endothelin type B receptor (ETB receptor) with IC50 values of 1.5 microM and 20 microM, respectively. Taxonomy of producing strains, fermentation, isolation, and physico-chemical properties of RES-1149-1 and -2 are described.
2. RES-1149-1 and -2, novel non-peptidic endothelin type B receptor antagonists produced by Aspergillus sp. II. Structure determination and derivatization
Y Uosaki, M Yoshida, T Ogawa, Y Saitoh J Antibiot (Tokyo). 1996 Jan;49(1):6-12. doi: 10.7164/antibiotics.49.6.
The structures of two novel non-peptidic endothelin type B receptor antagonists, RES-1149-1 and -2 were determined by spectroscopic methods. Several derivatives were synthesized from RES-1149-1 for biological assay.
3. RES-1149-1 and -2, novel non-peptidic endothelin type B receptor antagonists produced by Aspergillus sp. III. Biochemical properties of RES-1149-1, -2 and structure-activity relationships
T Ogawa, Y Uosaki, T Tanaka, E Tsukuda, A Mihara, Y Matsuda J Antibiot (Tokyo). 1996 Feb;49(2):168-72. doi: 10.7164/antibiotics.49.168.
RES-1149-1 and -2, produced by Aspergillus sp. RE-1149, were found to be non-peptidic antagonists for endothelin type B receptor (ET(B) receptor). RES-1149-1 and -2 selectively inhibited the endothelin-1 (ET-1) binding to ET(B) receptor in a competitive manner with IC50 values of 1.5 microM and 20 microM, respectively. RES-1149-1 inhibited the increase in intracellular Ca2+ concentration elicited by 1 nM ET-1 in COS-7 cells expressing human ET(B) receptor, but not in the case of cells expressing ET(A) receptor. In addition, some structure-activity relationships are described.
Recommended Products
| BBF-03781 | Resveratrol | Inquiry |
| BBF-03862 | Cefozopran hydrochloride | Inquiry |
| BBF-04621 | Artemisinin | Inquiry |
| BBF-02577 | Pneumocandin C0 | Inquiry |
| BBF-05827 | Spliceostatin A | Inquiry |
| BBF-03427 | Tubercidin | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳
